Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia.
about
Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.Heparin-induced thrombocytopenia: natural history, diagnosis, and management.Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia.Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients.Practical approach to the diagnosis and management of thrombocytopenia associated with tirofiban treatment.Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin.Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass.Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.Diagnosis and management of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia in a renal transplant recipient.Fondaparinux: a potential new therapy for HIT.Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia (an overview).Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.What is the potential for overdiagnosis of heparin-induced thrombocytopenia?Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.Optical density values correlate with the clinical probability of heparin induced thrombocytopenia.Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagnosis and treatment.Current concepts review: heparin-induced thrombocytopenia.Thrombin generation and heparin-induced thrombocytopenia.Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.Heparin-induced thrombocytopenia: current status and diagnostic challenges.Simple scoring system for early management of heparin-induced thrombocytopenia.A painful HIT.The utility of pre-test clinical scoring for clinical diagnosis of heparin-induced thrombocytopenia in cardiac surgery patients of a tertiary care centre in north India.Heparin-induced thrombocytopenia: present and future.Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients.Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.Dynamic antibody-binding properties in the pathogenesis of HIT.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Heparin-induced thrombocytopenia in the pediatric population: a review of current literatureHeparin-induced thrombocytopenia following hip and knee arthroplasty.Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.
P2860
Q33332774-C83072D0-C1D7-4FA9-BF80-FFB684DCEBCDQ33338785-7889C5C6-05AA-4BDA-8C77-F35B6CF37B2FQ33340202-5A99C3FB-5BB1-4A89-AC85-C013C95C24EDQ33343054-0B8490AC-7D70-485C-9F51-769311DFA661Q33348256-E870C239-4009-4F3F-8C42-BAF4E5135C08Q33349694-A32AAA5E-520C-4A90-B7FE-48313A6C66FAQ33362130-1F05A743-0619-4B8B-A2AD-BBDFAB8D0259Q33363358-C10A7EBF-CE03-49BB-B5E2-C3408F26B2DDQ33363740-477E93BD-8536-4419-8E2A-25F9428C6F31Q33364229-9DFA4D62-DB9E-4A32-A4A1-32874D1908EAQ33365985-05A3DA86-066C-47F0-A4A9-7014AA4C8D75Q33366262-6022A734-169A-40E1-8593-7279AA41325DQ33367708-AD0CF080-E321-4571-BF25-E40017DD92A1Q33369330-9AD2A6EB-7B3D-4D4A-92EF-1BAD22553140Q33371918-F0F5221B-0983-4D5B-98C2-F76976FA96E7Q33374563-A84CB8C6-507A-4343-A7F5-3C066BF805D2Q33376382-0B119253-38AC-4762-A38D-432D4E10EF9BQ33376726-EF58188F-B1CD-4878-9FF1-FE26EFE3A12AQ33377292-908F7914-E340-4C9D-88FA-9BACEA65F525Q33380506-6E49F483-ADDE-48CA-915D-9C1C4272101CQ33380931-032661A2-0C61-4D97-A941-B80804EE3361Q33381366-ACE66984-28E0-480A-97F9-9E8518197F00Q33382108-DFB3F7D2-03F1-4702-90DC-33E05C5B588EQ33385116-AF0C5392-4FE8-40B6-A2D1-E5ED662C8F0DQ33388783-5CBC6480-7223-4BB6-9691-886726B7BF47Q33391038-6E7DB26B-F8A5-4727-A78B-7DEB537A33FBQ33393295-0B4653C9-8E12-4E6E-8E3C-F8908D19C3F8Q33393585-BFA898B1-58B5-46AB-9CC7-8D9E062E6944Q33393837-A43CD1A1-69F4-4F42-A465-DD92BC112566Q33394188-7B67F9CF-F9B5-441C-A946-769D3E163822Q33395517-E3C92B00-9A34-40CB-A29A-5630F4CF2FB5Q33397294-EF256C40-C56F-401C-BBA7-17F2FB106CA3Q33399580-BD708792-2960-42FA-8FB5-94AB7572AC3FQ33399789-C95417CF-239C-4C20-B1DB-021AB5EB46C0Q33401163-B2910D17-0416-4559-A73A-5034262ABB7BQ33401466-B6DD7F36-3A52-45EF-AE0A-1146DFC19D0AQ33403395-CCAEE939-08A6-402D-BDC8-235490EF84F3Q33404178-DBB82C08-65B9-4C5C-9643-B86029CE6F77Q33405846-84497E4B-173B-4059-80BA-BFA5595B85C8Q33411785-B8030458-A0A1-4F59-9232-8C5707B369F5
P2860
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@ast
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@en
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@nl
type
label
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@ast
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@en
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@nl
prefLabel
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@ast
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@en
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@nl
P2093
P921
P356
P1476
Decision analysis for use of p ...... arin-induced thrombocytopenia.
@en
P2093
Delahousse B
Laporte-Simitsidis S
Pouplard C
P304
P356
10.1093/AJCP/111.5.700
P407
P577
1999-05-01T00:00:00Z